ClinConnect ClinConnect Logo
Search / Trial NCT06886568

Ultrasound Guided Ganglion Impar Block

Launched by BAŞAKŞEHIR ÇAM & SAKURA CITY HOSPITAL · Mar 19, 2025

Trial Information

Current as of April 29, 2025

Not yet recruiting

Keywords

Coccydynia Pain Ultrasound Guided Injection Ganglion Impar

ClinConnect Summary

This clinical trial is studying a treatment called a ganglion impar block, which uses ultrasound to help relieve chronic pain in the tailbone area, known as coccydynia. The goal is to see how effective and reliable this procedure is for patients who have been experiencing pain for at least three months and have not found relief from other treatments.

To participate, you need to be between 18 and 65 years old and scheduled for this specific procedure at a pain management clinic. However, if you have an infection where the injection would be given, a bleeding disorder, a history of allergic reactions to the medications being used, or if you are pregnant, you wouldn't be able to join the study. If you do participate, you can expect to undergo the ganglion impar block procedure and help researchers understand how well it works for people like you. This trial is currently not recruiting participants yet, but it aims to provide valuable insights into managing chronic coccygodynia.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age between 18-65 years.
  • Coccydynia persisting for at least three months.
  • Being scheduled for a ganglion impar block in the pain medicine outpatient clinic.
  • Having inadequate response to medical and conservative treatments.
  • Aggreeing to undergo the interventional procedure and participate in the study.
  • Exclusion Criteria:
  • Local infection at the injection site.
  • Bleeding disorders or diseases and drugs that may cause bleeding diatesis (e.g. renal failure, liver failure, anticoagulant treatments)
  • History of allergic reaction to the medications to be used.
  • Pregnancy

About Başakşehir çam & Sakura City Hospital

Başakşehir Çam & Sakura City Hospital is a leading healthcare institution in Turkey, renowned for its state-of-the-art facilities and commitment to patient-centered care. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical research and innovation across various therapeutic areas. With a multidisciplinary team of experts and a focus on ethical practices, Başakşehir Çam & Sakura City Hospital actively collaborates with industry partners and academic institutions to facilitate cutting-edge clinical trials, aiming to improve treatment outcomes and enhance the overall quality of healthcare.

Locations

Istanbul, Başakşehir, Turkey

Patients applied

0 patients applied

Trial Officials

Duygu Karali-Bingul, MD

Principal Investigator

Başakşehir Çam & Sakura City Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported